179 related articles for article (PubMed ID: 22886429)
1. Impact of the treatment-free interval on health-related quality of life in patients with multiple myeloma: a UK cross-sectional survey.
Acaster S; Gaugris S; Velikova G; Yong K; Lloyd AJ
Support Care Cancer; 2013 Feb; 21(2):599-607. PubMed ID: 22886429
[TBL] [Abstract][Full Text] [Related]
2. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life and quality-adjusted progression free survival for carfilzomib and dexamethasone maintenance following salvage autologous stem-cell transplantation in patients with multiple myeloma: a randomized phase 2 trial by the Nordic Myeloma Study Group.
Nielsen LK; Schjesvold F; Möller S; Guldbrandsen N; Hansson M; Remes K; Peceliunas V; Abildgaard N; Gregersen H; King MT
J Patient Rep Outcomes; 2024 Feb; 8(1):15. PubMed ID: 38315268
[TBL] [Abstract][Full Text] [Related]
4. Health related quality of life for multiple myeloma patients according to treatment strategy after autologous stem cell transplant: a cross-sectional study using EORTC, EQ-5D and MY-20 scales.
Tay J; Vij R; Norkin M; Buadi F; Kindwall-Keller TL; Roberts JS; White DJ; Wood RP; Blanthorn-Hazell SE; Rossi AC; Dhanasiri S; Zafar F; Newhouse K; McCurdy AR
Leuk Lymphoma; 2019 May; 60(5):1275-1282. PubMed ID: 30380358
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life of patients with multiple myeloma: A real-world study in China.
Li X; Liu J; Chen M; Gu J; Huang B; Zheng D; Li J
Cancer Med; 2020 Nov; 9(21):7896-7913. PubMed ID: 32881377
[TBL] [Abstract][Full Text] [Related]
6. Use of Bayesian Markov chain Monte Carlo methods to estimate EQ-5D utility scores from EORTC QLQ data in myeloma for use in cost-effectiveness analysis.
Kharroubi SA; Edlin R; Meads D; Browne C; Brown J; McCabe C
Med Decis Making; 2015 Apr; 35(3):351-60. PubMed ID: 25784746
[TBL] [Abstract][Full Text] [Related]
7. A prospective observational study to assess clinical decision-making, prognosis, quality of life and satisfaction with care in patients with relapsed/refractory multiple myeloma: the CLARITY study protocol.
Efficace F; Boccadoro M; Palumbo A; Petrucci MT; Cottone F; Cannella L; Zamagni E; Niscola P; Kyriakou C; Caravita T; Offidani M; Mandelli F; Cavo M
Health Qual Life Outcomes; 2018 Jun; 16(1):127. PubMed ID: 29914509
[TBL] [Abstract][Full Text] [Related]
8. Reliability and Validity of an Iranian Version of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for Patients with Multiple Myeloma: the EORTC QLQ-MY20.
Ahmadzadeh A; Yekaninejad MS; Saffari M; Pakpour AH; Aaronson NK
Asian Pac J Cancer Prev; 2016; 17(1):255-9. PubMed ID: 26838220
[TBL] [Abstract][Full Text] [Related]
9. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study.
Ramsenthaler C; Osborne TR; Gao W; Siegert RJ; Edmonds PM; Schey SA; Higginson IJ
BMC Cancer; 2016 Jul; 16():427. PubMed ID: 27387201
[TBL] [Abstract][Full Text] [Related]
10. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
Kiely F; Cran A; Finnerty D; O'Brien T
Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
[TBL] [Abstract][Full Text] [Related]
11. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
[TBL] [Abstract][Full Text] [Related]
12. Use of the European Organisation for Research and Treatment of Cancer multiple myeloma module (EORTC QLQ-MY20): a review of the literature 25 years after development.
Forde K; Cocks K; Wells JR; McMillan I; Kyriakou C;
Blood Cancer J; 2023 May; 13(1):79. PubMed ID: 37193682
[TBL] [Abstract][Full Text] [Related]
13. Quality of life in multiple myeloma: clinical validation of the Mexican-Spanish version of the QLQ-MY20 instrument.
Espinoza-Zamora JR; Portilla-Espinosa CM; Labardini-Méndez JR; Cervera E; Niesvisky R; Oñate-Ocaña LF
Ann Hematol; 2015 Jun; 94(6):1017-24. PubMed ID: 25563595
[TBL] [Abstract][Full Text] [Related]
14. Health-Related Quality of Life of Patients With Multiple Myeloma Treated in Routine Clinical Practice in France.
Despiégel N; Touboul C; Flinois A; Saba G; Suzan F; Gonzalez-McQuire S; Bonnetain F
Clin Lymphoma Myeloma Leuk; 2019 Jan; 19(1):e13-e28. PubMed ID: 30292736
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
16. Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma: The TOURMALINE-MM3 trial.
Schjesvold F; Goldschmidt H; Maisnar V; Spicka I; Abildgaard N; Rowlings P; Cain L; Romanus D; Suryanarayan K; Rajkumar V; Odom D; Gnanasakthy A; Dimopoulos M
Eur J Haematol; 2020 May; 104(5):443-458. PubMed ID: 31880006
[TBL] [Abstract][Full Text] [Related]
17. Health-Related Quality of Life and Satisfaction With Health Care: Relation to Clinical Stage in Mexican Patients With Multiple Myeloma.
Balderas-Peña LM; Miranda-Ruvalcaba C; Robles-Espinoza AI; Sat-Muñoz D; Ruiz MG; García-Luna E; Nava-Zavala AH; Rubio-Jurado B
Cancer Control; 2019; 26(1):1073274819831281. PubMed ID: 30786721
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Quality of Life Multiple Myeloma Module Questionnaire (QLQ-MY20) in Portuguese myeloma patients.
Graça Pereira M; Ferreira G; Pereira M; Faria S; Bacalhau R; Monteiro S; Fernandes B; Vilaça M
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13128. PubMed ID: 31273859
[TBL] [Abstract][Full Text] [Related]
19. Real-World Evaluation of Health-Related Quality of Life in Patients With Multiple Myeloma From Germany.
Engelhardt M; Ihorst G; Singh M; Rieth A; Saba G; Pellan M; Lebioda A
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e160-e175. PubMed ID: 33218965
[TBL] [Abstract][Full Text] [Related]
20. Patient-Reported Outcome Results From the Open-Label, Randomized Phase III Myeloma X Trial Evaluating Salvage Autologous Stem-Cell Transplantation in Relapsed Multiple Myeloma.
Ahmedzai SH; Snowden JA; Ashcroft AJ; Cairns DA; Williams C; Hockaday A; Cavenagh JD; Ademokun D; Tholouli E; Allotey D; Dhanapal V; Jenner M; Yong K; Cavet J; Hunter H; Bird JM; Pratt G; Parrish C; Brown JM; Morris TCM; Cook G;
J Clin Oncol; 2019 Jul; 37(19):1617-1628. PubMed ID: 30969846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
